Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pancreatic Neoplasms × Tegafur × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3 Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 151 130-nm albumin-bound paclitaxel 48 Albumin-Bound Paclitaxel 37 Oxaliplatin 29 Fluorouracil 29 Capecitabine 29 pembrolizumab 28 Radiotherapy 25 Leucovorin 25 Irinotecan 25 Erlotinib Hydrochloride 21 Nivolumab 20 Cisplatin 18 Taxes 17 Bevacizumab 14 Radiosurgery 11 Cyclophosphamide 11 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 Carboplatin 10 Paclitaxel 9 Docetaxel 9 Sorafenib 8 Ipilimumab 8 Biopsy 8 trametinib 7 poly ICLC 7 olaparib 7 folfirinox 7 fludarabine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03162510 2022-04-07

SOLAR

National Health Research Institutes, Taiwan

Phase 1 Completed

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡